Kerr/Pentron, DBA Kerr Corporation and Pentron Clinical recalls Nexus Universal with OptiBond Universal, Universal Adhesive Resin Cement, Trial Kit, Ref # 36990 - Product Usage: The i…
- Recall date
- February 25, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1824-2020
- FDA classification
- Class II
- Brand / firm
- Kerr/Pentron, DBA Kerr Corporation and Pentron Clinical
- Sold / distributed
- Worldwide distribution - US Nationwide distribution in the states of NV, TN, NY, WA, WI, GA, PA, TX, IN, FL, IL, IA, MD, CA, LA, , MI, AZ, NC, KY, SC and the country of Netherlands.
Why it was recalled
An issue within production process used to package trial kits let to the inclusion of the incorrect bonding agent for the kit. Use of the incorrect bonding agent may lead to increased risk of bond failures.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nexus Universal with OptiBond Universal, Universal Adhesive Resin Cement, Trial Kit, Ref # 36990 - Product Usage: The intended use of this device is to be used for the cementation of indirect restorations including veneers, inlays, onlays, bridges, posts, and the cementation of crown restorations to implant abutments.
Get recall alerts
Free email alert whenever Kerr/Pentron, DBA Kerr Corporation and Pentron Clinical has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Kerr/Pentron, DBA Kerr Corporation and Pentron Clinical